INTRODUCTION
It is no w known that T lymphocyte differentiation takes place within the microenvironment of the thymus, although the precise inductive and selective mechanisms whereby stromal cells of epithelial and haemopoietic origin are involved remain yet to be resolved (Marrack and Kappler, 1987; Boehmer, 1988) .
Although specific signals that induce cellular differentiation in the thymus have not been identified, T-cell development requires close interaction between thymic microenvironmental cells (epithelium, dendritic cells, and macrophages) and the developing lymphocytes (Stutman et al., 1969) . This interaction is likely to take two main forms: first, direct cell-cell contact involving cell-surface molecules, such as antigen receptors and MHC molecules, as well as accessory/adhesion molecules such as CD2, CD4, CD8, and LFA-3 (CD58); and second, interaction *Corresponding author. between soluble molecules, such as cytokines, and their cell-surface receptors (Bierer et al., 1989; Springer, 1990) .
A recent approach to the analysis of these intrathymic mechanisms has been to raise monoclonal antibodies (mAb) to molecules in/on thymic stromal cells (DeMaagd et al., 1985; Kanariou et al., 1989) . These reagents, raised to both human and rodent thymus, have revealed considerable heterogeneity within the epithelial component of the mammalian thymic microenvironment. One of these antibodies, 4F1, binds to all cortical epithelium and small patches of epithelial cells in the medulla of mouse thymus (Kanariou et al., 1989) , and in the recent workshops on thymic epithelial antibodies has been defined as a CTES (cluster of thymic epithelial staining) III reagent (Kampinga et al., 1989; Ladyman et al., 1991) .
In this paper, we describe structural and functional analysis of the molecule to which 4F1 binds (4F1-Ag). Our data indicate that the 4F1-Ag may represent a novel adhesion molecule that is involved in both intrathymic T lymphocyte differentiation and peripheral T-cell function.
RESULTS
Distribution and Expression of the 4F1-Ag The 4F1 rat mAb has previously been shown to label strongly all cortical epithelium and to give weak staining of small patches of epithelium in the medulla of mouse thymus (Kanariou et al., 1989) .
Immunocytochemical staining of the Thy-myc transgene-derived thymoma cell lines TM25.F1 (epithelial), TM25.103, and TM25.114 (mixed epithelial and lymphoid) (Spanopoulou et al., 1989) confirmed the reactivity of 4F1 with epithelial cells, but showed that transformed lymphoid cells were also strongly positive (Fig. 1) . These cells provided a useful source of antigen. Flow (a) cytometric analysis showed high expression of 4F1-Ag on the surface of TM25.114 lymphocytes (Table 1 4. The same bands are seen for both lymphoid and epithelial cells.
5. The expression of individual bands is variable, but this shows no correlation with cell type (see Figs. 7, 8, and 9) , and is seen in both the presence and absence of protease inhibitors.
6. A ladder pttern is observed behind the bands throughout the gel, and for all cell types analyzed. However, we have also observed this with other IgM mAbs.
Glycosylation of the 4F1-Ag was analyzed using either tunicamycin in culture or by treating cells with endoglycosidase F (endo F). When cells were grown in the presence of tunicamycin, there was a reduction in the intensity of the two upper bands (Fig. 8) . However, in our system, the presence of tunicamycin, even at2tg/ml, blocked adherence of the cells to each other and to the tissue-culture flasks and appeared to inhibit their growth. Further studies of glycosylation, therefore, were performed using endo F. After treatment of cells with this enzyme, only the 43-kD band remained, and this was considerably reduced in intensity (Fig. 9 ). Treatment with OGlycanase had no effect on any of the bands.
Analysis of membrale insertion of the 4F1-Ag on TM25.F1 epithelial cells using PI-PLC showed that there was no difference between the Western blots of treated and untreated cells. Similarly, PI-PLC had no effect on transformed lymphocytes (TM25.114 and BW5147) when treated in suspension prior to analysis by flow cytometry. In contrast, PI-PLC treatment of fresh frozen thymic tissue sections showed a partial but significant reduction in the fluorescence intensity of 4F1 staining (Table 3 ; Fig. 10 ). The effect of PI-PLC on Thy-1 staining (positive control, known to be PIlinked) was considerably greater, whereas the enzyme had no effect on either MHC class-II or IVC4-1abeling intensities (negative controls, not PI-linked).
DISCUSSION
The aim of the work presented in this paper was to explore the nature and function of the molecule detected by mAb 4F1. This mAb was initially raised against cortical epithelium of mouse thymus. However, our data indicate that the 4F1-Ag is present both within the thymus and in the periphery, and that it may be involved in T-cell Springer, 1990) . Alternatively, the presence of several bands could reflect differences in glycosylation, as has been observed for Thy-1 (Williams, 1988 although the significance of a PI-versus-transmembrane linkage is currently unclear (Presky et al., 1990; Springer, 1990) . Analysis of the glycosylation of the 4F1 molecule showed that both tunicamycin and endo F treatment resulted in a reduction in the intensity of some 4F1-Ag bands. However, no lower molecular weight band representing a deglycosylated form appeared, nor was the smallest form (29 kD) enhanced. The most likely explanation of (Knapp et al., 1990) . Although there are several welldescribed adhesion molecules such as LFA-3 (CD58), ICAM-1 (CD54), Leu 8 (p90 , Pgp-1 (CD44), and NCAM (CD56) (Sadoul et al., 1986; Marlin and Springer, 1987; Springer et al., 1987; Sanders et al., 1988; Camerini et al., 1989) , only LFA-3 shares similar distribution, structure, and functional characterstics with the 4F1 molecule, because it is up-regulated upon activation (Krensky et al., 1983; Sanders et al., 1988) , has a similar range of relative molecular weight , and is anchored into the cell membrane via both the PI-linked and transmembrane forms Seed, 1987) .
However, 4F1-Ag differs from LFA-3 in that it is expressed on cortical thymic epithelium, but not in the medulla, and LFA-3 is present on both cortical and medullary epithelium (with stronger expression in the medulla) (Singer and Haynes, 1987 ; our unpublished observations). 4F1-Ag is absent from red blood cells and endothelium (personal observations) contrary to LFA-3 . Biochemical analysis of 4Fl-Ag gives four discrete bands (29, 32, 40, and 43 kD) and that of LFA-3 gives a broad band around 65kD (surface) and 35/39kD and 37/41 kD (internal) (Singer and Haynes, 1987 (2 g/l), penicillin (100 IU/ml) and streptomycin (100/g/ml) (Flow).
Source of Antibodies
4F1: MAb 4F1 is a rat IgM reagent that was raised to epithelial cells of the mouse thymic cortex (Kanariou et al., 1989) . IVC4: mAb IVC4 is a rat IgM reagent that detects epithelial cells of the mouse thymic medulla (Kanariou et al., 1989 Phosphatidylinositol-specific phospholipase C (PI-PLC) isolated from Bacillus thuringiensis, with activity 336/tmol/min/ml, was used to treat whole TM25.F1 cells (Pierres et al., 1987 analyzed by flow cytometry as described before.
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